Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DORZOLAMIDE vs DOXEPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DORZOLAMIDE vs DOXEPIN: Safety Overview

Metric DORZOLAMIDE DOXEPIN
Total FAERS Reports 3,814 4,021
Deaths Reported 8 1,613
Death Rate 0.2% 40.1%
Hospitalizations 144 1,091
Average Patient Age 65.9 yrs 49.2 yrs
% Female Patients 60.6% 63.8%
FDA Approval Date Apr 13, 2009 Approved Prior to Jan 1, 1982
Manufacturer Florida Pharmaceutical Products, LLC Teva Pharmaceuticals USA, Inc.
Route OPHTHALMIC TOPICAL
Marketing Status Discontinued Discontinued